Nautilus Biotechnology (NAUT) Capital Expenditures (QoQ) (2020 - 2026)
Nautilus Biotechnology (NAUT) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Nautilus Biotechnology |
289.99 Mn |
194.12 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
109.02% |
| Dec 31, 2025 |
-41.63% |
| Sep 30, 2025 |
5.56% |
| Jun 30, 2025 |
80.82% |
| Mar 31, 2025 |
-13.78% |
| Dec 31, 2024 |
-64.17% |
| Sep 30, 2024 |
38.48% |
| Jun 30, 2024 |
-20.87% |
| Mar 31, 2024 |
56.66% |
| Dec 31, 2023 |
-52.75% |
| Sep 30, 2023 |
88.77% |
| Jun 30, 2023 |
-33.09% |
| Mar 31, 2023 |
202.18% |
| Dec 31, 2022 |
-76.22% |
| Sep 30, 2022 |
47.93% |
| Jun 30, 2022 |
35.34% |
| Mar 31, 2022 |
-51.22% |
| Dec 31, 2021 |
265.19% |
| Sep 30, 2021 |
-49.15% |
| Jun 30, 2021 |
10.17% |
